ELAVL1 and gastric cancer: Furthermore, circ-HuR can bind CCHC-type zinc finger nucleic acid binding protein (CNBP), inhibit CNBP-promoted human antigen R (HuR) expression and the development of gastric cancer, and may become a potential therapeutic target for gastric cancer (30).